Join

Compare · AGL vs FMS

AGL vs FMS

Side-by-side comparison of agilon health inc. (AGL) and Fresenius Medical Care AG (FMS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AGL and FMS operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
  • FMS is the larger of the two at $19.85B, about 3.3x AGL ($6.03B).
  • AGL has been more active in the news (7 items in the past 4 weeks vs 1 for FMS).
  • AGL has more recent analyst coverage (25 ratings vs 21 for FMS).
MetricAGLFMS
Company
agilon health inc.
Fresenius Medical Care AG
Price
$26.01-0.80%
$22.76+0.02%
Market cap
$6.03B
$19.85B
1M return
+143.08%
-
1Y return
-72.94%
-
Industry
Misc Health and Biotechnology Services
Misc Health and Biotechnology Services
Exchange
NYSE
NYSE
IPO
2021
News (4w)
7
1
Recent ratings
25
21
AGL

agilon health inc.

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.

FMS

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.